Understanding HIV Causes, Symptoms and HIV Medicine: ACRIPTEGA FROM MYLAN

Role of Medicine – ACRIPTEGA FROM MYLAN in HIV Treatment – Causes, Symptoms and Benefits

Acriptega from Mylan is a highly demanded medicine for HIV. A major global health issue that affects millions of people globally is HIV (Human Immunodeficiency Virus). Because of the immune system’s weakened state, people are more prone to getting sick and getting infected. In this blog post, we’ll look at the causes, signs, and effects of HIV as well as the advantages of the medication ACRIPTEGA FROM MYLAN, which is frequently used to treat HIV infection.

Causes of HIV:

1. Unprotected Sexual Intercourse: The risk of HIV transmission rises when sexual activity is conducted without the use of protections like condoms.
2. Sharing Needles: The spread of HIV can occur when users of intravenous medication share needles and other drug accessories.
3. Mother-to-Child Transmission: HIV can spread through infected blood transfusions or organ transplants, despite being rare nowadays because to better blood screening.
4. Blood Transfusion: Although rare nowadays due to improved blood screening, HIV can be transmitted through contaminated blood transfusions or organ transplants.

Symptoms of HIV:

1. Initial Flu-Like Symptoms: People may suffer symptoms similar to the common flu within a few weeks of infection, including fever, lethargy, sore throat, enlarged lymph nodes, and body aches.
2. Asymptomatic Stage: After the early symptoms subside, HIV can enter a dormant state during which time a person may not show any symptoms at all for several years.
3. Advanced Stage (AIDS): HIV can develop into AIDS (Acquired Immunodeficiency Syndrome) if it is not treated. Rapid weight loss, ongoing diarrhoea, a lingering fever, night sweats, repeated infections, and excessive weariness are possible symptoms.

ACRIPTEGA FROM MYLAN and its Role in HIV Treatment:

A combination medication called ACRIPTEGA FROM MYLAN contains Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg). Due to its efficacy and safety description, it is frequently given for the management of HIV infection.

1. Dolutegravir: It is a member of the integrase inhibitor class of antiretroviral medications. The integrase enzyme, which the virus uses to integrate its genetic material into human cells, is inhibited by dolutegravir. The virus’s ability to replicate is stopped by preventing this phase.
2. Lamivudine: It is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits an enzyme called reverse transcriptase. This enzyme is crucial for the replication of the virus. By interfering with the reverse transcription process, Lamivudine helps to slow down the progression of HIV infection.
3. Tenofovir disoproxil fumarate: Another NRTI, Tenofovir disoproxil fumarate also targets the reverse transcriptase enzyme, impeding the replication of the virus. It has been shown to be effective in reducing the viral load and improving immune function in HIV patients.

Benefits of ACRIPTEGA FROM MYLAN:

1. Highly Effective: ACRIPTEGA FROM MYLAN has demonstrated excellent efficacy in suppressing HIV replication, reducing the viral load, and maintaining the CD4 cell count (a key indicator of immune health).
2. Convenience: The combination tablet simplifies treatment regimens by combining three active ingredients into a single pill, enhancing patient compliance and reducing the risk of missing doses.
3. Side Effect: ACRIPTEGA FROM MYLAN is generally well-tolerated, with minimal side effects reported. However, as with any medication, it is important to consult a healthcare professional to monitor its use and address any concerns.

Conclusion:

HIV infection poses significant health risks, but with proper treatment and medication, such as ACRIPTEGA FROM MYLAN, individuals living with HIV can lead fulfilling lives while effectively managing the virus. It is crucial to raise awareness about HIV prevention, early detection, and the availability of medications like ACRIPTEGA FROM MYLAN to ensure a healthier future for all.